Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andreas Geier

Showing results (201-210 of 249) with videos related to

Pageof 25
Sort By:
Aging and Disease|June 12, 2023
The inhibition of YAP Signaling Prevents Chronic Biliary Fibrosis in the Abcb4<sup>-/-</sup> Model by Modulation of Hepatic Stellate Cell and Bile Duct Epithelium Cell PathophysiologyLiangtao Ye, Andreas Ziesch, Julia S Schneider, et al.
Alimentary Pharmacology & Therapeutics|April 4, 2025
Therapeutic Sequences of Systemic Therapy After Atezolizumab Plus Bevacizumab for Hepatocellular Carcinoma: Real-World Analysis of the IMMUreal CohortNajib Ben Khaled, Valentina Zarka, Bernard Hobeika, et al.
Plos One|July 19, 2012
A genetic validation study reveals a role of vitamin D metabolism in the response to interferon-alfa-based therapy of chronic hepatitis CChristian M Lange, Stephanie Bibert, Zoltan Kutalik, et al.
Zeitschrift Fur Gastroenterologie|July 8, 2024
Elke Roeb, Ali Canbay, Heike Bantel, et al.
Journal of Lipid Research|May 23, 2019
Elevated oxysterol levels in human and mouse livers reflect nonalcoholic steatohepatitisTina Raselli, Tom Hearn, Annika Wyss, et al.
JHEP Reports : Innovation in Hepatology|February 20, 2026
Mycobiome dysbiosis and genetic predisposition to elevated IL-17A contribute to fibrosis in MASLDNadja Thielemann, Sara Leal Siliceo, Monika Rau, et al.
Cellular Oncology (Dordrecht, Netherlands)|June 16, 2025
Efficacy of CDK4/6 Inhibition in colorectal cancer and the role of p16 expression in predicting drug resistanceJulia S Schneider, Najib Ben Khaled, Liangtao Ye, et al.
JHEP Reports : Innovation in Hepatology|July 15, 2024
Rare HCV subtypes and retreatment outcomes in a cohort of European DAA-experienced patientsJulia Dietz, Christiana Graf, Christoph P Berg, et al.
EMBO Molecular Medicine|May 5, 2021
Protein Kinase D2 drives chylomicron-mediated lipid transport in the intestine and promotes obesityJonathan Trujillo-Viera, Rabih El-Merahbi, Vanessa Schmidt, et al.
Plos One|February 29, 2024
Machine learning approaches to enhance diagnosis and staging of patients with MASLD using routinely available clinical informationMatthew McTeer, Douglas Applegate, Peter Mesenbrink, et al.
Pageof 25

Showing results (201-210 of 249) with videos related to

Sort By:
Pageof 25
Aging and Disease|June 12, 2023
The inhibition of YAP Signaling Prevents Chronic Biliary Fibrosis in the Abcb4<sup>-/-</sup> Model by Modulation of Hepatic Stellate Cell and Bile Duct Epithelium Cell PathophysiologyLiangtao Ye, Andreas Ziesch, Julia S Schneider, et al.
Alimentary Pharmacology & Therapeutics|April 4, 2025
Therapeutic Sequences of Systemic Therapy After Atezolizumab Plus Bevacizumab for Hepatocellular Carcinoma: Real-World Analysis of the IMMUreal CohortNajib Ben Khaled, Valentina Zarka, Bernard Hobeika, et al.
Plos One|July 19, 2012
A genetic validation study reveals a role of vitamin D metabolism in the response to interferon-alfa-based therapy of chronic hepatitis CChristian M Lange, Stephanie Bibert, Zoltan Kutalik, et al.
Zeitschrift Fur Gastroenterologie|July 8, 2024
Elke Roeb, Ali Canbay, Heike Bantel, et al.
Journal of Lipid Research|May 23, 2019
Elevated oxysterol levels in human and mouse livers reflect nonalcoholic steatohepatitisTina Raselli, Tom Hearn, Annika Wyss, et al.
JHEP Reports : Innovation in Hepatology|February 20, 2026
Mycobiome dysbiosis and genetic predisposition to elevated IL-17A contribute to fibrosis in MASLDNadja Thielemann, Sara Leal Siliceo, Monika Rau, et al.
Cellular Oncology (Dordrecht, Netherlands)|June 16, 2025
Efficacy of CDK4/6 Inhibition in colorectal cancer and the role of p16 expression in predicting drug resistanceJulia S Schneider, Najib Ben Khaled, Liangtao Ye, et al.
JHEP Reports : Innovation in Hepatology|July 15, 2024
Rare HCV subtypes and retreatment outcomes in a cohort of European DAA-experienced patientsJulia Dietz, Christiana Graf, Christoph P Berg, et al.
EMBO Molecular Medicine|May 5, 2021
Protein Kinase D2 drives chylomicron-mediated lipid transport in the intestine and promotes obesityJonathan Trujillo-Viera, Rabih El-Merahbi, Vanessa Schmidt, et al.
Plos One|February 29, 2024
Machine learning approaches to enhance diagnosis and staging of patients with MASLD using routinely available clinical informationMatthew McTeer, Douglas Applegate, Peter Mesenbrink, et al.
Pageof 25